Properties of Pervanadate and Permolybdate
CONNEXIN43, PHOSPHATASE INHIBITION, AND THIOL REACTIVITY AS MODEL SYSTEMS*

Svein-Ole MikalsenDagger § and Olav Kaalhus

From the Departments of Dagger  Environmental and Occupational Cancer and  Biophysics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Pervanadate and permolybdate are irreversible protein-tyrosine phosphatase inhibitors, with IC50 values of 0.3 and 20 µM, respectively, in intact cells. Maximal inhibition was obtained within 1 min at higher concentrations of the compounds. They induced prominent changes in the phosphorylation status of the gap junction protein, connexin43. These effects were utilized as model systems to assess the stability and inactivation of the compounds. Although the concentrated stock solutions were relatively stable, the diluted compounds were unstable. The biological activity had decreased to 20-30% after 6 h of incubation in a phosphate buffer, 1 h in phosphate buffer with 10% fetal calf serum, and 1-3 minutes in culture medium. Thiols reacted rapidly with the compounds and inactivated them (initial reaction rates with cysteine: permolybdate > pervanadate > H2O2). Catalase inactivated the compounds, and permolybdate was the more sensitive. The cells inactivated permolybdate faster than pervanadate. Cellular inactivation of permolybdate, and to a lesser degree pervanadate, appeared to be partly dependent on catalase and thiols. However, a general decrease in cellular thiols was not the mediator of the biological effects of pervanadate or permolybdate. Mathematical modeling of the thiol reactivity suggested that monoperoxovanadate at maximum could possess 20% of the biological activity of diperoxovanadate.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Tyrosine phosphorylation is a central regulatory mechanism with numerous participating tyrosine kinases and counteracting protein-tyrosine phosphatases (PTPases)1 (1). Metal ions like vanadate and molybdate are PTPase inhibitors (2-4) that probably mimic inorganic phosphate. Many of the PTPase inhibitors are of low potency, especially in intact cells (5-8). Interestingly, the combination of vanadate and H2O2, two PTPase inhibitors of relatively low potency in intact cells, generates a much more potent inhibitor called pervanadate (PV) (9) with a specificity differing from that of vanadate (10). PV has been assumed to be vanadyl hydroperoxide (11-14), but the biological activity is fully compatible with PV being diperoxovanadate (7). This conclusion is in line with analytical approaches (see Ref. 7). A mixture of molybdate and H2O2, permolybdate (PMo), has many of the same properties as PV (14-16), but there are also differences (16). The biological activity of PMo is consistent with PMo being diperoxomolybdate or tetraperoxodimolybdate (16). PV and PMo have strong effects on cellular tyrosine phosphorylation (7, 16), and they affect several enzymes and other regulatory molecules (11, 13, 14, 17, 18). The compounds also induce tyrosine phosphorylation of the gap junction protein connexin43 (Cx43) (8), and they affect gap junctional intercellular communication (7, 12, 16).

PV may be somewhat unstable under certain conditions (9). The procedure for generating PV and PMo can have a significant effect on the stabilities, and thereby also the potencies, of the compounds (7, 16). However, there are no studies that have been fully dedicated to this problem. Because they are potent and useful experimental compounds with some potential for clinical therapies (15, 19), it was of interest to perform such an investigation. We have here studied some factors that influence the stability and inactivation of PV and PMo. We show that the compounds are rapidly inactivated under normal cell culture conditions and that several factors are involved in the inactivation.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Chemicals-- Catalase (2× crystallized), N-ethylmaleimide (NEM), sodium orthovanadate (Na3VO4), 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB), 3-amino-1,2,4-triazole (amitrole) and para-nitrophenyl phosphate (pNPP) were purchased from Sigma. H2O2 and sodium molybdate (Na2MoO4 × 2H2O) were obtained from Aldrich.

Preparation of Peroxocompounds-- The concentration of the parent metal salt was always considered as the concentration of the peroxocompound. Throughout this work we have based the concentrations of vanadate on epsilon 265 = 2925 M-1cm-1 (20), although other values can also be found in the literature (epsilon 260 = 3550 M-1cm-1 (21); in this case the concentrations will be 18.5% lower than shown). PV was made as a 30 mM stock solution using 60 mM H2O2 (7). PMo was made as a 100 mM stock solution. HCl (120 mM) was added before 200 mM H2O2 (16). The mixtures were incubated for 15 min in the dark at room temperature before use. The compounds were often diluted in Ca2+/Mg2+-supplemented phosphate buffered saline (PBSS) (137 mM NaCl, 2.7 mM KCl, 1.45 mM KH2PO4, 6.45 mM Na2HPO4, 0.5 mM CaCl2, 0.8 mM MgCl2, pH 7.2) or in Ca2+/Mg2+-supplemented Hepes-buffered saline (HBSS) (10 mM Hepes, 140 mM NaCl, 0.5 mM CaCl2, 0.8 mM MgCl2, pH 7.2).

Cell Cultures-- Primary cell cultures from Syrian hamster (Wright, Chelmsford, Essex, UK) embryos were prepared as described (7, 12). The cells were used between passages 2 and 10. No differences in responses were found between early and later passages. The growth medium was Dulbecco's modified Eagle's medium (DMEM) (Bio-Whittaker, Walkersville, NY) with 10% fetal calf serum (FCS) (Life Technologies, Inc.) and no antibiotics. The cells were maintained at 37 °C in a humidified 10% CO2 atmosphere. When the cells were incubated in PBSS or HBSS, no CO2 was added to the atmosphere.

Western Blotting-- The cells were seeded in 35-mm dishes. They reached confluence 2 days later. The cells were then exposed as indicated. They were rinsed in phosphate-buffered saline, scraped into electrophoresis sample buffer, and sonicated. Five µl (8-10 µg of protein) of the homogenate were used for electrophoresis and Western blotting as described previously (7, 12), using rabbit anti-Cx43 antiserum (7, 12) and an anti-phosphotyrosine monoclonal antibody (4G10, Upstate Biotechnology, Lake Placid, NY) as primary antibodies. The band shift of Cx43 induced by PV (7) or PMo (16) is fully developed after 15 min of exposure. The standard exposure time in this work, unless otherwise indicated, was therefore 15 min. Densitometry of blots were performed using NIH Image software2 on scans obtained with an Agfa Arcus scanner.

Phosphatase (pNPPase) Assay-- PTPases hydrolyze pNPP efficiently (4, 15, 22). pNPPase activity was measured as described (4, 22), with some modifications to achieve measurements on cells grown in 96-well plates. Cells (15,000 per well) were grown overnight. They were then exposed to the compounds in HBSS or PBSS (usually for 15 min) and rinsed in HBSS before the enzyme assay. Phosphatase assay buffer (50 µl of 37.5 mM sodium acetate, pH 5.0, 30% (w/v) glycerol, 1.5 mM EDTA, 0.15% Triton X-100, 5 mM freshly added DTT) was added directly to each well followed by 25 µl of 16 mM pNPP. Triton X-100 was included to obtain a rapid lysis of the cells. The detergent did not affect the pNPPase activity. DTT was increased to 5 mM to quench any remaining PV or PMo (see below). The plates were incubated at 37 °C for 1 h. The reaction was stopped by adding 50 µl of 3 M unbuffered Tris. The reactions were linear with regard to time and number of cells. The absorbance was read at 405 nm. The pNPPase data are shown as mean ± S.D. for n = 3-4, each in four parallel measurements, except for the kinetics data, which are shown as mean ± S.D. of 4 single independent measurements.

Determination of Remaining Biological Activity-- The remaining biological activities were determined by the dose-dependent shift in alterations of the Cx43 band pattern or by the dose-dependent shift in IC50 values of pNPPase. In both cases, the dose-response curve of test-treated (e.g. PV preincubated with in PBSS for 6 h) cultures were compared with the dose-response curve from control-treated cultures, i.e. PV or PMo diluted in PBSS and immediately added to the cells. Note that the 0 h incubation period in reality is a 1-3-min incubation due to the handling of dilutions and cells. The Western blot data shown are taken from one of several similar experiments.

Measurement of Nonprotein Thiols-- DTNB was used to measure cysteine in a cell-free reaction mixture and nonprotein thiols in cells (23). For the former, 0.5 ml of 0.2 M phosphate buffer (pH 7.5), 420 µl of water, 50 µl of sample, and 20 µl of DTNB (60 mM in Me2SO) were mixed. The samples were made by mixing PV, PMo, H2O2, or the parent metal salts with cysteine in appropriate amounts. Aliquots (50 µl) were withdrawn after different periods of time, and the remaining cysteine was measured at 412 nm.

We modified the DTNB assay of glutathione to avoid the extraction of trichloroacetic acid with ether. The sensitivity is equal to that of the previous method. The dishes were washed twice in phosphate-buffered saline, and 500 µl of 5% trichloroacetic acid were added per dish. The cells were scraped off the dishes and transferred to 1.5-ml microcentrifuge tubes followed by sonication. The tubes were centrifuged at 10,000 × g for 15 min, and the supernatant was used as sample. The assay buffer (pH 9.6) was 0.75 M in both phosphate and Tris. The sample volume was diluted to 730 µl with 5% trichloroacetic acid and mixed with 20 µl of DTNB (60 mM in Me2SO). Assay buffer (250 µl) was added before a rapid vortexing, and absorbance at 412 nm was read. After mixing of all ingredients, the pH will be between 7.2 and 7.5.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Inhibition of Phosphatases by PV and PMo

PV and PMo inhibit cytosolic PTPase with IC50 values of 3.3 and 10 µM, respectively, in a cell-free system (15). However, PMo was probably generated in a suboptimal way by Li et al. (15). It was therefore of interest to investigate the relative potencies of phosphatase inhibition of the compounds in intact cells. The cells were exposed to PV, PMo, and the parent compounds vanadate, molybdate, and H2O2 during 15-min exposures in HBSS. Vanadate or molybdate slightly inhibited pNPPase at very high concentrations (Fig. 1), indicating reversibility of inhibition and/or low permeability into cells. H2O2 caused an inhibition of pNPPase activity, with IC50 = 1000 µM (Fig. 1). PV and PMo were significantly more potent than their parent compounds. PV inhibited pNPPase activity, with IC50 = 0.3 µM; for PMo, IC50 = 20 µM (Fig. 1). Around 20-25% of the pNPPase activity remained at high concentrations of PV or PMo, similar to previous observations with PV (24). Similar results were also obtained when the cells were exposed in PBSS.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Inhibition of pNPPase activity in cells. Cells were grown in 96-well plates. With the exception of NEM pre-exposure (dotted curves), the cells were exposed for 15 min to the compounds diluted in HBSS before assaying the pNPPase activity. The activity in unexposed cells was defined as 100% activity (corresponds to 1.35 nmol/µg of protein/h; n = 24). The data are shown as mean ± S.D. (n = 3-4, each in four parallel measurements). black-square, vanadate; black-diamond , molybdate; black-down-triangle , H2O2; diamond , PMo; square , PV. Dotted lines, cells were also exposed to NEM in growth medium for 15 min followed by a 15 min incubation in HBSS (down-triangle), 30 µM NEM in growth medium for 15 min followed by PMo in HBSS for 15 min (diamond ), or 30 µM NEM in growth medium for 15 min followed by PV in HBSS for 15 min (square ).

The pNPPase assay is simple and rapid, but it depends on the amount of cellular protein. On the other hand, induction of altered phosphorylation status of the gap junction protein Cx43, as evaluated by Western blot (7, 8, 12, 16), is less sensitive to variations in the amount of protein. Cx43 was therefore used as the principal model system to study the stability and inactivation of PV and PMo. The inhibition of pNPPase was used as a complementary approach.

Inactivation under Normal Cell Culture Conditions

In control cells, Cx43 showed a pattern of three major and some minor bands (Fig. 2). The lower major band is the nonphosphorylated (NP) form of Cx43, and the two upper major bands are phosphorylated forms (P1 and P2) (12). The P2 band was sometimes split into a double band (e.g. Fig. 2D), and a faint band (P') often appeared immediately above the NP band. Cells exposed to PV or PMo for 15 min showed prominent changes in the phosphorylation status (Fig. 2, A and B; see also densitometric scans in Fig. 3C), characterized by decreased intensity of the NP band, a smear in the P1-P2 area, and the appearance of a band (P") immediately below P1. The intensity of the P" band could vary somewhat between the experiments (compare Figs. 2 and 3).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 2.   Inactivation of PV and PMo under normal cell culture conditions. P, prestained standards with apparent molecular mass (in kDa) indicated to the left. Con, control. The compounds were diluted in growth medium before addition to the cells. Cx43 band pattern was detected as described under "Materials and Methods." A, dose response to PV. NP and phosphorylated (P', P", P1, and P2) forms of Cx43 are marked on the right. B, dose response to PMo. C, cells were exposed to 10 µM PV in growth medium. Every 15 min, the medium was transferred to another dish, and samples for Western blotting were immediately prepared from the previous dish. The numbers indicate the time from addition of PV to the medium. D, the cells were treated as in C, but 300 µM PMo was used.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3.   Dose responses for PV and PMo in cells incubated in PBSS. The compounds were diluted in PBSS before addition to the cells. The exposure period was 15 min. Cx43 band pattern was detected as described under "Materials and Methods." A, dose response to PV. B, dose response to PMo. C, densitometric scans of the blots shown in A and B. The short lines under the start of each curve correspond to the base line of the densitogram. The curve for 30 µM PMo is dashed to better distinguish it from the neighboring curve.

At least some of the PV- and PMo-induced cellular changes are reversible during continuous exposure (7, 16). This could be due to regeneration of phosphatase activity in the cells (see below) and/or a decrease in concentration of the biologically active compounds in the medium. A transfer protocol was employed to investigate the latter possibility. One dish was exposed, and after 15 min, the spent medium was transferred to previously unexposed cells, and so on. PV (10 µM) was inactivated within 45-60 min, i.e. the active concentration of PV in the medium had become <2 µM (Fig. 2C). The biological activity of PMo (300 µM) decreased to below detectable level, i.e. <70 µM, within 60-75 min (Fig. 2D). Thus, the concentration of the biologically active compounds decreased during normal cell culture conditions. Three factors were likely to be involved: spontaneous inactivation, inactivation by factors in the growth medium (i.e. medium itself or FCS), or inactivation by the cells.

Spontaneous Breakdown and Inactivation by Exogenous Catalase

Catalase has traditionally been added to the PV stock solutions to break down excess H2O2. PV has been claimed to be rather resistant against catalase (10, 17). Our preliminary observations did not fully support this interpretation. It was first necessary to investigate the stability of the compounds in a buffer without catalase. We chose PBSS because this is a buffer that our cells tolerate well during incubations of up to 30 min and because phosphate is present in the medium. Both PV and PMo were more potent when the cells were incubated in PBSS than in the growth medium (compare Fig. 2, A and B, to Fig. 3, A and B). This suggested that components in the growth medium could inactivate the compounds (see below). PMo and PV were relatively stable (no measurable breakdown) for at least 6 h when kept in stock solution at room temperature and protected from light as measured by the Cx43 and pNPPase assays (not shown). When incubated in diluted solutions (0.15-20 µM PV or 6-300 µM PMo in PBSS) in the dark at 37 °C, both compounds showed an evident time-dependent breakdown (Fig. 4A). After 6 h of incubation, around 20-30% of the original potencies were present as indicated by both Cx43 and pNPPase assays (Fig. 4A).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Breakdown of PV and PMo in PBSS and by catalase. A, spontaneous breakdown. The compounds were diluted in PBSS to concentrations of 0.2-30 µM for PV (square  and black-square) and 6-600 µM for PMo (triangle ), incubated at 37 °C in the dark for the given periods, and then added to the cells. The remaining biological activity was determined by Cx43 band changes (square  and triangle ) or pNPPase activities (black-square (dotted curve)). The symbol might be slightly displaced to avoid overlapping. B, inactivation by catalase. The compounds were diluted to 1 mM in PBSS and added catalase. The mixtures were incubated at 37 °C in the dark for the given periods and then added in various concentrations to the cells in PBSS for 15 min to determine the remaining biological activity as described. black-square, PV and 2 µg/ml catalase; square , PV and 20 µg/ml catalase; black-diamond , PMo and 0.02 µg/ml catalase; diamond , PMo and 0.2 µg/ml catalase.

PV and PMo were clearly sensitive to catalase. The compounds lost their ability to induce the characteristic band shift of Cx43 in a manner dependent on both the incubation time with catalase and the amount of catalase, but PMo was 100-fold more sensitive to catalase (Fig. 4B). The reason for the higher sensitivity to catalase of PMo is uncertain, but in crystals, the Mo---Operoxo bonds are 0.1 Å longer than the V---Operoxo bonds (25). There may, therefore, be less steric hindrance involved in catalase approaching the peroxo-groups in PMo. The inactivation of PV by exogenous catalase is apparently in contrast to previous results (17), in which a rapid inactivation of PV was found when catalase was added simultaneously with the mixing of vanadate and H2O2. The inactivation was slower when catalase was added 10 min or more after mixing (17). When catalase was added in the present experiments, it was done 15 min after mixing of metal salts and H2O2. The catalase-induced inactivation is dependent on the amount of added enzyme (Fig. 4B). By extension, the inactivation also depend on the specific activity of the enzyme. Our results are consistent with analytical work showing that PV is degraded by catalase at a rate of 1-2% of that of H2O2 (26). Interestingly, high concentrations of PV partly inhibit the catalase action on H2O2 (26).

Inactivation by FCS or DMEM

Various concentrations of PV or PMo were incubated in PBSS with 10% FCS or in DMEM (without FCS) for periods between 0 and 6 h before exposure to the cells for 15 min. The mixing of the compounds with PBSS/FCS rapidly (1-3 min, see "Materials and Methods") inactivated around 30% of the activity in the diluted solutions (Fig. 5A). Thereafter followed a slower breakdown, leaving 5-10% of the activity after 6 h of incubation (Fig. 5A).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Inactivation of PV and PMo by FCS and DMEM. A, inactivation by FCS. The compounds were treated as described in the legend to Fig. 4A, with the exception that PBSS with 10% FCS was used. The symbols are as described in the legend to Fig. 4A. They might be slightly displaced to avoid overlapping. B, inactivation by DMEM. The compounds were treated as described in the legend to Fig. 4A, with the exception that DMEM was used.

DMEM was an efficient inactivator of the diluted compounds. By 1-3 min after mixing, 70-80% of the biological activity had disappeared. After 1 h of preincubation, less than 5% of the activity remained (Fig. 5B). In contrast, when 1 mM PV was preincubated in DMEM for 1 h and then diluted and assayed in PBSS, around 70% of the activity remained (not shown). This suggests that there are ingredients at relatively low concentrations in the DMEM that rapidly inactivate the compounds. A practical implication is that the potencies of PV and PMo are partly dependent on the exact procedure during the exposure.

Reaction of Peroxocompounds with Cysteine

The reaction of thiols with PV and PMo is of interest for two reasons. First, cysteine is the reactive part of glutathione, a major detoxification system in cells. Second, PV and PMo are PTPase inhibitors. All PTPases have a cysteine residue in the active site, which could be a participant in the inhibitory effect of the peroxocompounds. We have therefore used cysteine as the major model compound in studies of the reaction between thiol and peroxocompounds. It has been reported that glutathione may reduce vanadate to vanadyl in cells (Ref. 27; see also Ref. 28) and that glutathione could react with PV and PMo in a 1:1 molar ratio (15).

The consumption of cysteine was measured during the reaction with the peroxocompounds by a spectrophotometric assay (Fig. 6). We also determined the remaining biological activity after such reactions (see Fig. 11). H2O2 caused 5-15% of the cysteine to be consumed within 5 s. The curves approximately followed one-phase exponential decay irrespective of whether 1, 2, or 3 molar equivalents of cysteine were added. There was no remaining cysteine after 15 min of reaction time (Fig. 6A). Vanadate needed about 2 h to consume an equimolar amount of cysteine, and the curve followed an approximately linear decay (Fig. 6B). PV showed a more complex consumption curve. There was a very rapid initial decrease in cysteine, corresponding to approximately one consumed cysteine during the first 5 s, and then another cysteine consumed at 120 s (Fig. 6B, inset). The subsequent decrease was approximately linear with time, paralleling that of vanadate-induced removal of cysteine (Fig. 6B). Indeed, UV spectrophotometric measurements showed that the reaction product of PV and thiol possessed a peak at the same wavelength (265 nm at pH 11.0) and height as expected for vanadate, but with higher absorbance at lower wavelengths (not shown). The peak was fully developed at 1.5-2 molar equivalents of cysteine added.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   The reaction between cysteine and H2O2 (A), PV (B), and PMo (C). Cysteine was mixed with the peroxocompounds in molar ratios (cysteine:peroxocompounds) of 1:1 (square ), 2:1 (triangle ), 3:1 (open circle , except for PV), or 4:1 (down-triangle), and the remaining cysteine was measured after different periods of time ranging from 5 s to 24 h. For better comparison, the 3:1 ratio of cysteine:PV is shown also in A and C (bullet , dashed line). The reactions between the 1:1 ratio of cysteine and the parent (black-square, dotted line) metal salts, vanadate and molybdate, are shown in B and C, respectively. The insets in A and B show the reaction between cysteine and H2O2 and between cysteine and PV, respectively, during the first 60 s. The shaded bar in C shows the remaining cysteine after 24 h of incubation in a mixture without metal salts or peroxocompounds and thus represent the stability of cysteine in the present buffer. For clarity, the deviations are not shown. For most points, S.D. is <15% of the mean value shown; n = 4-5.

Molybdate reacted very slowly with cysteine. After 24 h of reaction, 60% of the cysteine still remained (Fig. 6C). As a control, reaction mixtures with only cysteine contained 81 ± 6% (mean ± S.D.; n = 11) of free SH groups after 24 h (Fig. 6C). PMo consumed approximately two cysteines during the first 5-10 s and another cysteine within 30 s (Fig. 6C). The fourth cysteine was consumed within 5 min. UV spectrophotometric measurements showed that the reaction product possessed a peak at the nearly the same wavelength as molybdate (250 versus 253 nm, measured in 1:1 mixture of 50 mM glycine, pH 3.0, and PBSS) but 5-10% higher than molybdate (not shown). The peak was fully developed at 3.5-4 molar equivalents of cysteine added.

The results shown in Fig. 6 are in contrast to results obtained by Li et al. (15). They found both PV and PMo to consume thiol at a 1:1 ratio. We therefore measured the consumption of thiols using a procedure that more closely approached their conditions (Hepes buffer, constant concentration of thiol, and varying the concentration of PV or PMo). We still found the consumption of thiol to be 2:1 and 4:1 (thiol:peroxocompound) for PV and PMo, respectively (not shown). The difference may partly be explained by their suboptimal generation of PMo and their use of catalase to remove excess H2O2.

The initial rate of reaction with cysteine was PMo > PV > H2O2. This can be explained by the more strained, and therefore more reactive, bonds in the triangular V/Mo---Operoxo structure than in the H2O2 molecule. According to Shaver et al. (29), heteroliganded PV compounds oxidize more cysteine to cystine during a 4 h period than does vanadate, but less than H2O2. The heteroliganded compounds may therefore be less reactive. Thus, the heteroligand may cause sterical hindrance for the attacking thiol, or the thiol is attacking via the position occupied by water in PV but by the heteroligand in the heteroliganded compounds. Both our observations and the results of Shaver et al. (29) lend support to the concept that the biological effects of peroxocompounds are due to reaction with active site cysteine in PTPases (30) and other enzymes. PMo and H2O2 probably act through a similar mechanism.

Kinetics and Irreversibility of pNPPase Inhibition

It was previously observed that PMo induced a faster accumulation of phosphotyrosine in cells than did PV (7, 16). We asked whether this was reflected in a faster inhibition of pNPPase activity in intact cells due to the faster reaction with thiols. Concentrations that resulted in 60-70% inhibition of pNPPase activity were chosen. PMo (30 µM) caused a near immediate 50% inhibition of pNPPase activity (Fig. 7). PV (1 µM) gave a near immediate 20% inhibition, followed by a slow increase in the inhibition up to 15 min (Fig. 7A). A higher concentration of PV (30 µM) caused a near immediate 45% inhibition of pNPPase, and maximal inhibition was obtained after 1 min (Fig. 7A). The difference is therefore apparently caused by a larger concentration gradient over the cell membrane.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   Kinetics and irreversibility of pNPPase inhibition in intact cells by PV and PMo. A, cells grown in 96-well plates were exposed to PV (square , 1 µM; black-square, 30 µM) or PMo (diamond , 30 µM) in HBSS for periods of 5 s to 15 min. The compounds were then removed, and the cells were washed once in HBSS before assaying the pNPPase activity. The data are shown as mean ± S.D. of four independent experiments. B, cells grown in 96-well plates were exposed to 1, 3, 10, or 30 µM PV (square , triangle , down-triangle, and diamond , respectively; dotted curves) or 30, 100, 300, or 1000 µM PMo (black-square, bullet , black-triangle, and black-down-triangle , respectively; solid curves) in growth medium for the indicated times. The pNPPase activity was then measured as described. The data are shown as mean ± S.D. of three independent experiments, each in four parallel measurements. The apparently lower potency of the compounds is due to inactivation by the medium (see Fig. 5). The 4-h exposure to 1000 µM PMo was cytotoxic and is not included.

The reversibility of pNPPase inhibition was investigated. PV oxidizes the cysteine in the active site of PTPases to its -SO3H derivative (30) and is therefore assumed to be an irreversible inhibitor. However, the cellular tyrosine phosphorylation, changes in Cx43 band pattern, and the decreased gap junctional intercellular communication are readily reversible for the lower concentrations of the compounds (7, 16). Cycloheximide (10-100 µM) did not appreciably affect pNPPase activity during 4-h exposures (not shown), suggesting a low turnover of pNPPases. PV and PMo caused inhibition of pNPPase activity that only slightly and slowly recovered during continuous exposure in growth medium (Fig. 7B). Very similar curves were obtained if the cells were exposed to the compounds for 15 min, washed, and allowed to recover for periods between 15 min and 4 h (not shown). Two explanations can be offered for the seemingly paradoxical observation that some biological effects are reversible, whereas the phosphatase activity is irreversibly inhibited: (i) the reversibility of the changes in Cx43 band pattern and gap junctional intercellular communication (7, 16) may be due to the rapid turnover of the gap junction proteins, and (ii) PV activates several tyrosine kinases (13, 31, 32), probably indirectly. Some of them are transiently activated (32). The kinases may be inactivated by PTPases not inhibited by the lower concentrations of the compounds. The cellular PTPase activity is supposed to be 2-3 orders of magnitude higher than the tyrosine kinase activity and will therefore, in the longer term, dominate over the tyrosine kinase activity unless the majority of the PTPases are inhibited. Further studies are needed to substantiate these suggestions.

Inactivation by Cells

Enzymes Inhibited by Amitrole-- From the results above, endogenous catalase could be one candidate for an inactivation system of the compounds. Catalase (and some other peroxidases) is inhibited by amitrole (see Ref. 33). Incubation overnight with 6 mM amitrole decreased catalase activity to about 20% of normal (33, 34). Amitrole had no effect on Cx43 band pattern alone, and there were minimal changes in the dose response of Cx43 to PV or PMo in cells pre-exposed to amitrole (not shown).

A transfer protocol was used to evaluate the ability of cells to inactivate PV and PMo. The cells were exposed to the compounds in PBSS for 30 min before transfer of the buffer to the next dish. PMo (100 µM) was inactivated by nonpretreated cells after two 30-min incubations (Fig. 8, A and B, left panels). In amitrole-treated cells, PMo was inactivated substantially slower, needing four or five 30-min incubations before decreasing below detectable levels (Fig. 8, A and B, right panels). More than 6 h is needed to spontaneously inactivate 100 µM PMo (not shown, but compare Figs. 3B and 4A). Thus, PMo is at least partly inactivated by enzymes inhibited by amitrole.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 8.   Importance of cellular amitrole-inhibitable enzymes in inactivation of PMo. A, PMo was diluted in PBSS to 100 µM and added to PBSS-washed cells in 35-mm dishes. The cells had been pretreated with growth medium alone (left panel) or with 6 mM amitrole (middle panel) for 18 h before the cells were rinsed. Amitrole was also present during the incubation with PMo. After 30 min of incubation, the buffer containing the compounds was transferred to the next dish, which had received an identical pretreatment, and samples were prepared from the first dishes. After another 30 min of incubation, a new transfer was done, and so on. Cx43 band pattern was detected as described under "Materials and Methods." B, densitometric scans of key lanes from the blots shown in A. Note that the normalization of the Cx43 band pattern after PMo-exposure is delayed in amitrole-exposed cells.

When the cells were exposed to 5 µM PV, the Cx43 band pattern normalized after two or three transfers, i.e. 1-1.5 h of incubation (not shown). More than 6 h is needed to spontaneously inactivate 5 µM PV (not shown, but compare Figs. 3A and 4A). Thus, the cells inactivated PMo around 20-fold faster than PV. Amitrole-treated cells lagged only slightly behind the inactivation of PV by the control cells (not shown). This suggested that cellular catalase (or other amitrole-inhibited peroxidases) is only of minor importance for the inactivation of PV. The cells used in the present work are embryonic fibroblasts with a relatively low content of catalase (34, 35). Endogenous catalase may be of greater importance in cells with high catalase content. For example, rat hepatocytes have approximately 400-fold higher activity of catalase than Syrian hamster embryo cells (35). The difference in sensitivity of PV and PMo to endogenous catalase is consistent with the sensitivity of the compounds for exogenous catalase (Fig. 4B).

Cellular Thiols-- NEM was used to deplete the cells for thiols. Nonprotein thiols (i.e. mainly glutathione) were measured in cells exposed to NEM and peroxocompounds for 15 min. Unexposed cells contained 3.54 ± 0.74 nmol of nonprotein thiols/106 cells (Table I). This corresponds to an intracellular concentration of approximately 2 mM, assuming a cellular volume corresponding to a radius of 7.5 µm. NEM (30 µM) significantly depleted the nonprotein thiols in cells (Table I). After removal of NEM (30 µM), the level of cellular nonprotein thiols remained at the same low level for more than 30 min (not shown). The lower biologically active concentrations of PV (up to 30 µM) or PMo (up to 300 µM) did not significantly affect the level of cellular nonprotein thiols (Table I), whereas a high concentration of H2O2 (10 mM) did. Thus, the biological effect of PV and PMo is not mediated through a general decrease in glutathione.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effect of NEM, PV, PMo, and H2O2 on cellular nonprotein thiol level
Confluent 100-mm dishes were exposed to the compounds for 15 min before the samples were made as described under "Materials and Methods." Unexposed control cells contained 10.4 ± 3.4 nmol of non protein thiols/mg of protein (mean ± S.D.; n = 8) and 3.54 ± 0.74 nmol of non protein thiols/106 cells (mean ± S.D.; n = 8). n = 6 for NEM and PV; n = 3 for PMo and H2O2.

NEM at 100-300 µM showed some phosphotyrosine-inducing effect (Fig. 9A, upper panel), and it inhibited pNPPase activity with IC50 = 30 µM (Fig. 1). This is consistent with previous observations (36). Cells exposed to PV or PMo in PBSS for 15 min strongly increased the amount of phosphotyrosine at concentrations at and above 1 and 20 µM, respectively (Fig. 10A and data not shown).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 9.   NEM affects cellular tyrosine phosphorylation and Cx43. Cells were exposed to various concentrations of NEM in growth medium for 15 min before samples were made. A, upper panel, blot developed with anti-phosphotyrosine as the primary antibody; lower panel, the same samples developed with the anti-Cx43 antiserum. B, densitometric scans of the Cx43 blot from A. Only the control and the 100 and 300 µM NEM lanes are shown. Note the changes occurring from 100 to 300 µM NEM in the P'/P" area.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 10.   NEM pre-exposure affects the responses to PMo. Cells were treated with PMo in PBSS (A) or pre-exposed to 30 µM NEM in growth medium before the exposure to PMo in PBSS (B and C). The blots were developed for detection of phosphotyrosine (A and B) or Cx43 (C). The phosphotyrosine blots have been relatively weakly developed to avoid saturation, causing bands in the control lanes not to be visible. D, cells were pre-exposed to 30 µM NEM in growth medium for 15 min, rinsed, and then exposed to 100 µM PMo in PBSS. Every 30 min, the PMo/PBSS was transferred to next dish (also pre-exposed to NEM), and the previous dish was sampled for Western blotting. The blot was developed for detection of Cx43. The corresponding control (no preincubation to NEM) is shown in Fig. 8 (left panel). E, densitometric scans of key lanes from C and D. Note that the Cx43 P' is very prominent in cells sequentially exposed to NEM and PMo. Note also that the normalization of band pattern is delayed in cells sequentially exposed to NEM and PMo (compare with Fig. 8).

Interestingly, the sequential exposure to NEM (30 µM, giving approximately 50% inhibition of pNPPase activity) and PV or PMo did not increase the maximal inhibition of pNPPase (Fig. 1). Furthermore, the pre-exposure to NEM did not appreciably affect the IC50 values of PV or PMo (calculated from the difference between the inhibition by 30 µM NEM and the maximal inhibition; Fig. 1). The sequential exposure to NEM (30 µM for 15 min in growth medium) and peroxocompounds (various concentrations for 15 min in PBSS) caused a slight increase in cellular phosphotyrosine relative to peroxocompounds alone at low concentrations (compare Fig. 10, A and B). The maximal amount of phosphotyrosine obtained at higher concentrations of the peroxocompounds after the sequential exposure was not substantially affected (Fig. 10, A and B).

NEM affected the Cx43 band pattern only at high concentration (300 µM) (Fig. 9A, lower panel, and B). The sequential exposure to NEM (30 µM for 15 min) followed by PMo did not change the concentration of PMo where the first alterations in the Cx43 band pattern started to occur, but the response pattern of Cx43 was different (compare Figs. 2B, 3B, and 10C). The P' band, or a band very close to this position, became much more evident in the NEM/PMo exposed cells relative to other exposures. Furthermore, the smear in the P1-P2 area was clearly less pronounced after the sequential exposure (compare Figs. 2B and 3B with Fig. 10, C and D, and compare the densitometric scans in Figs. 3C and 10E). At high concentrations of PMo (300-1000 µM), the P' band weakened and the NP band became more intense again (Fig. 10, C and E). The sequential exposure to NEM (30 µM for 15 min) and PV caused the cells to become slightly less sensitive to PV, needing approximately double the concentration of PV for the first changes in the Cx43 band pattern to occur (not shown). The P' band was less pronounced than that for PMo (not shown). The sequential exposure to NEM and PV also caused less smear in the P1-P2 area than did PV alone (not shown).

The transfer assay was used to investigate whether NEM (30 µM, 15 min) pre-exposure slowed the inactivation of the peroxocompounds. The sequential exposure to NEM and PMo showed that PMo was inactivated more slowly by NEM pretreated cells than by control cells (compare Fig. 8, left panels, and Fig. 10, D and E). Apparently, PV (5 µM) was inactivated at the same rate as in control cells (not shown), but taking the lower sensitivity in NEM pre-exposed cells into account, the inactivation time was probably somewhat increased. Thus, cellular thiols are probably involved in the inactivation of both compounds.

An interesting question is whether PV and PMo have the same cellular targets. Obviously, PMo is less potent than PV, but the difference can be exaggerated by a suboptimal generation of PMo. For example, PV was found to activate the mitogen-activated protein kinase pathway, whereas PMo minimally did so (24). In our hands, the compounds induced a similar pattern in cellular protein tyrosine phosphorylation, including a strong tyrosine phosphorylation in a band at around 43 kDa (see Fig. 10A). This band is not Cx43,3 but it may originate from a mitogen-activated kinase. However, the subtle differences in the band pattern changes of Cx43 in the response to the two compounds alone or in the combination with NEM could suggest that the inhibitory specificities are not totally overlapping. Furthermore, in contrast to PV, high concentrations of PMo (1000 µM) tended to slightly decrease the amount of cellular phosphotyrosine (Fig. 10 and Ref. 16), and the dose responses as measured by gap junctional intercellular communication are very different. Therefore, the possibility that at high concentrations of PMo may have one or more targets not affected by PV cannot be excluded.

Thiol-induced Inactivation of PV and PMo: Mathematical Model

The remaining biological activity by the peroxocompounds was studied after the reaction with thiols. Thiols (cysteine or DTT) were added to PV (1 mM in PBSS) in ratios of 0.5:1, 0.75:1, 1:1, 1.25:1, or 1.5:1 (molar equivalents of thiol groups:PV). After an incubation period of 20 min, the mixture was added to the cells in concentrations ranging from 0.15 to 100 µM PV (in PBSS) using small increments in concentration, especially below 1 µM. Although 1.5 mM cysteine nearly abolished the biological activity of PV (>1-3% left), around 10, 20, 40, and 50% activity was present after incubation with 1.25, 1, 0.75, and 0.5 molar ratios of thiols, respectively (Fig. 11A). Similar to the reactions described in Fig. 6, PMo needed double the amount of thiols relative to PV for the inactivation (Fig. 11B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 11.   Model of remaining biological activity of PV (A) or PMo (B) after reaction with thiols. The peroxocompounds were made as 30 or 100 mM stock solutions as described. They were diluted in PBSS to 1 mM. To the PV solution, cysteine (100 mM stock solution in water) was added to 0.5, 0.75, 1, 1.25, or 1.5 mM, or DTT (50 mM stock solution in water) was added to 0.25, 0.375, or 0.5 mM. To the PMo solution, cysteine was added to 1, 2, or 3 mM, or DTT was added to 0.5, 1, or 1.5 mM. After 20 min of incubation at 37 °C in the dark, volumes of the solutions were added to cells in PBSS to obtain concentrations of 0.2-100 µM for PV and 6-1000 µM for PMo. After another 15 min of incubation, samples were prepared for Western blotting. The Cx43 pattern changes were always compared with dose responses obtained from incubations without any additions of thiols, and the remaining biological activities were calculated. Hatched bar, cysteine; solid bar, DTT. The dotted curves show the calculated biological activity when k1/k2 = 1/2 and the monoperoxocompounds are devoid of biological activity. See text for more details.

We first considered PV as the model compound. PV was assumed to possess two initially equal peroxo groups per metal ion (7). The thiol compound was assumed to be inactivated by the reaction. The nonperoxocompound (presumably vanadate; see Fig. 6B and the corresponding text) was assumed to be biologically inactive in the present system (7) and not to interact with thiol groups over the time scale of interest (see Fig. 6B). We assumed the following reactions.

Some simple models can easily be rejected or are not likely. For example, suppose that thiols react much more efficiently with the diperoxocompound than with the monoperoxocompound, i.e., k2 >>  k1. Then all diperoxocompound molecules will react with thiols before any reaction between thiols and the monoperoxocompounds occur. In this case, the best fit is obtained when monoperoxovanadate has a biological activity of 16 ± 5% (mean ± S.D.) relative to diperoxovanadate. This model gives a break in the curvature at 1 thiol added, with linear curves between 0 and 1, and between 1 and 2 added thiols (not shown). This appears not to fit well with the measured biological activity. Conversely, when k1 >>  k2, the monoperoxocompound will only exist in negligible amounts, and the biological activity should decrease linearly with the amount of thiols added up to 2. Thus, k1 >>  k2 can be dismissed, and it is not likely that k2 >>  k1.

We assumed that the concentrations of the various peroxidation states C0 (nonperoxovanadate), C1 (monoperoxovanadate), and C2 (diperoxovanadate), and the concentration of thiol groups (as cysteine or DTT), CSH, were governed by the following reaction equations.
dC<SUB>2</SUB>/dt=<UP>−</UP>k<SUB>2</SUB>·C<SUB>2</SUB>·C<SUB><UP>SH</UP></SUB> (Eq. 1)
dC<SUB>1</SUB>/dt=k<SUB>2</SUB>·C<SUB>2</SUB>·C<SUB><UP>SH</UP></SUB>−k<SUB>1</SUB>·C<SUB>1</SUB>·C<SUB><UP>SH</UP></SUB> (Eq. 2)
dC<SUB><UP>SH</UP></SUB>/dt=<UP>−</UP>(k<SUB>2</SUB>·C<SUB>2</SUB>+k<SUB>1</SUB>·C<SUB>1</SUB>)·C<SUB><UP>SH</UP></SUB> (Eq. 3)
As expected, combining Equations 1-3 gave the equation,
d(2C<SUB>2</SUB>+C<SUB>1</SUB>)/dt=dC<SUB><UP>SH</UP></SUB>/dt (Eq. 4)
because the consumption of reducing and oxidizing equivalents must be equal. It can be seen from Equation 4 that if the biological activity of the diperoxo state is twice that of the monoperoxo state, the biological activity would decrease linearly with the amount of thiol used. The data in Fig. 11 show a curve convex toward the thiol axis, indicating that the diperoxo state has more than twice the biological activity of the monoperoxo state.

If we assumed that the diperoxo state alone has biological activity, the curve could be found when we solved for C2 as a function of CSH. The solution was particularly simple when krel = k1/k2 = 1/2, i.e. when the thiol reacted independently and with the same rate with each peroxo group. We assumed a prior complete peroxidation, i.e. the initial concentration of the monoperoxo state was zero (C1i = 0). This is in agreement with the published reaction constants (37), giving an equilibrium concentration of C2 sime  98% and C1 ~<  0.2% of the vanadate supplied. We further assumed that the reaction with thiol was complete, i.e. the final concentration of thiol was zero (CSHf = 0). The final concentration of the diperoxo state (C2f) was then shown by the equation,
C<SUB>2f</SUB>=C<SUB>2i</SUB>·(1−(C<SUB><UP>SH</UP>i</SUB>/C<SUB>2i</SUB>)<SUP>2</SUP>/4) (Eq. 5)
where C2i and CSHi are the initial concentrations. In Fig. 11A, the curve corresponding to Equation 5 is depicted. It can be seen that this curve indicates a biological activity slightly higher than the measured biological activity. This suggested that krel < 1/2.

When krel  1/2, the inverse solution was as follows,
C<SUB><UP>SH</UP>i</SUB>=C<SUB>2i</SUB>·(2−(2−<UP>ln</UP>(C<SUB>2f</SUB>/C<SUB>2i</SUB>))·C<SUB>2f</SUB>/C<SUB>2i</SUB>) (Eq. 6)
for k1 = k2, and
C<SUB><UP>SH</UP>i</SUB>=C<SUB>2i</SUB>·(2−(1−k<SUB>1</SUB>/(k<SUB>2</SUB>−k<SUB>1</SUB>))·C<SUB>2f</SUB>/C<SUB>2i</SUB> (Eq. 7)
−k<SUB>2</SUB>/(k<SUB>2</SUB>−k<SUB>1</SUB>)·(C<SUB>2f</SUB>/C<SUB>2i</SUB>)<SUP>k<SUB>1</SUB>/k<SUB>2</SUB></SUP>)
for k1  k2.

From the discussion above, it was unlikely that k1 = k2. Using Equation 7, the numerical solutions gave the best fit to the measured biological data when krel = k1/k2 = 0.31 ± 0.07. (Note that if the alternative value for the extinction coefficient, epsilon 260 = 3550 M-1cm-1, was used, a reasonable fit was achieved when krel = 1.02 ± 0.30 if monoperoxovanadate has no biological activity. On the other hand, a better fit was produced if we assumed that krel = 1/2. Then, monoperoxovanadate would have a biological activity of 14 ± 3% relative to diperoxovanadate.)

For PMo, a similar model was employed, with the exception that four reducing equivalents of thiols were used to completely reduce the highest peroxidation state. The biological activities and the theoretical curves corresponding to Equation 5 are shown in Fig. 11, A and B. The best fit was obtained at krel = 0.33 ± 0.06. We are presently not able to explain why PMo can consume four thiols versus two thiols for PV, but we note that measurements by three methods (thiol consumption, UV spectrophotometry, and biological activities) are consistent with respect to this difference.

From the above results, it seems likely that the monoperoxo state of PV has a low biological activity, at maximum 20% relative to diperoxovanadate. Both diperoxovanadate and monoperoxovanadate are assumed to possess a seven-coordinated pentagonal bipyramidal geometry (25, 38, 39). Because of the reactivity of the peroxo group with thiols, we had expected the monoperoxovanadate to have a considerable biological activity. In support, some heteroliganded monoperoxovanadates show PTPase inhibitory effects of the same degree as the corresponding heteroliganded diperoxovanadates, as determined by insulin receptor dephosphorylation in rat liver endosomes (40). In contrast, Huyer et al. (30) used the previously calculated equilibrium constants for the peroxo forms of vanadate (37) to conclude that the monoperoxovanadate is a less potent inhibitor of PTP1B, adding that the monoperoxo form may not be inhibitory at all. We note, however, that Huyer et al. (30) added 0.4 µM of peroxovanadates to a reaction mixture containing 10 µg/ml catalase, 5 mM DTT, and 200 ng/ml PTP1B. Thus, there appear to be ample possibilities for adverse reactions in their assay. Therefore, it is still premature to conclude that monoperoxovanadate is devoid of all biological activity. To this end, more analytical methods, e.g. NMR, must be used together with measurements of biological activity.


View larger version (6K):
[in this window]
[in a new window]
 
Reaction 1.  
    ACKNOWLEDGEMENTS

We gratefully acknowledge Pauline Gorton and Grete Berntsen for technical assistance. We thank Dr. T. Sanner for valuable discussions and Dr. E. Rivedal for making the antiCx43 antiserum available to us.

    FOOTNOTES

* This work was supported by grants from the Blix Family's Fund for the Advance of Medical Research (to S.-O. M.), Anders Jahre's Fund (to S.-O. M and Dr. T. Sanner), and funds from the Faculty of Medicine, University of Oslo (to S.-O. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 47-2293-4705; Fax: 47-2293-5767; E-mail: s.o.mikalsen{at}labmed.uio.no.

1 The abbreviations used are: PTPase, protein-tyrosine phosphatase; Cx43, connexin43; pNPP, para-nitrophenyl phosphate; DTNB, 5,5'-dithio-bis(2-nitrobenzoic acid); NEM, N-ethylmaleimide; PBSS, phosphate-buffered saline supplemented with Ca2+ and Mg2+; HBSS, Hepes-buffered saline supplemented with Ca2+ and Mg2+; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; DTT, dithiothreitol; PV, pervanadate; PMo, permolybdate; NP, nonphosphorylated.

2 The NIH Image software is obtainable on the Internet by anonymous file transfer protocol from ftp://zippy.nimh.nih.gov.

3 S.-O. Mikalsen, unpublished observations.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

  1. Sun, H., and Tonks, N. K. (1994) Trends. Biochem. Sci. 19, 480-485[CrossRef][Medline] [Order article via Infotrieve]
  2. Lerea, K. M., Tonks, N. K., Krebs, E. G., Fischer, E. H., and Glomset, J. A. (1989) Biochemistry 28, 9286-9292[Medline] [Order article via Infotrieve]
  3. Swarup, G., Cohen, S., and Garbers, D. L. (1982) Biochem. Biophys. Res. Commun. 107, 1104-1109[Medline] [Order article via Infotrieve]
  4. Tonks, N. K., Diltz, C. D., and Fischer, E. H. (1988) J. Biol. Chem. 263, 6731-6737[Abstract/Free Full Text]
  5. Heffetz, D., Bushkin, I., Dror, R., and Zick, Y. (1990) J. Biol. Chem. 265, 2896-2902[Abstract/Free Full Text]
  6. Kole, H. K., Smyth, M. S., Russ, P. L., and Burke, T. R., Jr. (1995) Biochem. J. 311, 1025-1031[Medline] [Order article via Infotrieve]
  7. Mikalsen, S.-O., and Kaalhus, O. (1996) Biochim. Biophys. Acta 1290, 308-318[Medline] [Order article via Infotrieve]
  8. Mikalsen, S.-O., Husøy, T., Vikhamar, G., and Sanner, T. (1997) FEBS Lett. 401, 271-275[CrossRef][Medline] [Order article via Infotrieve]
  9. Kadota, S., Fantus, I. G., Deragon, G., Guyda, H. J., Hersh, B., and Posner, B. I. (1987) Biochem. Biophys. Res. Commun. 147, 259-266[Medline] [Order article via Infotrieve]
  10. Fantus, I. G., Kadota, S., Deragon, G., Foster, B., and Posner, B. I. (1989) Biochemistry 28, 8864-8871[Medline] [Order article via Infotrieve]
  11. Pumiglia, K. M., Lau, L.-F., Huang, C.-K., Burroughs, S., and Feinstein, M. B. (1992) Biochem. J. 286, 441-449[Medline] [Order article via Infotrieve]
  12. Husøy, T., Mikalsen, S.-O., and Sanner, T. (1993) Carcinogenesis 14, 2257-2265[Abstract]
  13. Imbert, V., Peyron, J. F., Farahi Far, D., Mari, B., Auberger, P., and Rossi, B. (1994) Biochem. J. 297, 163-173[Medline] [Order article via Infotrieve]
  14. Haque, S. J., Flati, V., Deb, A., and Williams, B. R. G. (1995) J. Biol. Chem. 270, 25709-25714[Abstract/Free Full Text]
  15. Li, J., Elberg, G., Gefel, D., and Shechter, Y. (1995) Biochemistry 34, 6218-6225[Medline] [Order article via Infotrieve]
  16. Mikalsen, S.-O., and Kaalhus, O. (1997) Biochim. Biophys. Acta 1356, 207-220[CrossRef][Medline] [Order article via Infotrieve]
  17. Kadota, S., Fantus, I. G., Deragon, G., Guyda, H. J., and Posner, B. I. (1987) J. Biol. Chem. 262, 8252-8256[Abstract/Free Full Text]
  18. Bourgoin, S., and Grinstein, S. (1992) J. Biol. Chem. 267, 11908-11916[Abstract/Free Full Text]
  19. Shisheva, A., Ikonomov, O., and Shechter, Y. (1994) Endocrinology 134, 507-510[Abstract]
  20. Goodno, C. C. (1982) Methods Enzymol. 85, 116-123[Medline] [Order article via Infotrieve]
  21. Gordon, J. A. (1991) Methods Enzymol. 201, 477-482[Medline] [Order article via Infotrieve]
  22. Zhao, Z., Bouchard, P., Diltz, C. D., Shen, S.-H., and Fischer, E. H. (1993) J. Biol. Chem. 268, 2816-2820[Abstract/Free Full Text]
  23. Ellman, G. L. (1959) Arch. Biochem. Biophys. 82, 70-77[Medline] [Order article via Infotrieve]
  24. Zhao, Z., Tan, Z., Diltz, C. D., You, M., and Fischer, E. H. (1996) J. Biol. Chem. 271, 22251-22255[Abstract/Free Full Text]
  25. Svensson, I.-B., and Stomberg, R. (1971) Acta Chem. Scand. 25, 898-910
  26. Ravishankar, H. N., Rao, A. V. S., and Ramasarma, T. (1995) Arch. Biochem. Biophys. 321, 477-484[CrossRef][Medline] [Order article via Infotrieve]
  27. Macara, I. G., Kustin, K., and Cantley, L. C., Jr. (1980) Biochim. Biophys. Acta 629, 95-106[Medline] [Order article via Infotrieve]
  28. Li, J., Elberg, G., Crans, D. C., and Shechter, Y. (1996) Biochemistry 35, 8314-8318[CrossRef][Medline] [Order article via Infotrieve]
  29. Shaver, A., Ng, J. B., Hall, D. A., Lum, B. S., and Posner, B. I. (1993) Inorg. Chem. 32, 3109-3113
  30. Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsaprailis, G., Gresser, M. J., and Ramachandran, C. (1997) J. Biol. Chem. 272, 843-851[Abstract/Free Full Text]
  31. Secrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A., and Abraham, R. T. (1993) J. Biol. Chem. 268, 5886-5893[Abstract/Free Full Text]
  32. Evans, G. A., Garcia, G. G., Erwin, R., Howard, O. M. Z., and Farrar, W. L. (1994) J. Biol. Chem. 269, 23407-23412[Abstract/Free Full Text]
  33. Mikalsen, S.-O., Kaalhus, O., Reith, A., and Sanner, T. (1990) Int. J. Cancer 46, 950-957[Medline] [Order article via Infotrieve]
  34. Mikalsen, S.-O., and Sanner, T. (1994) Carcinogenesis 15, 381-387[Abstract]
  35. Mikalsen, S.-O., Ruyter, B., and Sanner, T. (1990) Biochem. Pharmacol. 39, 527-535[Medline] [Order article via Infotrieve]
  36. Ståhls, A. (1992) Biochem. Biophys. Res. Commun. 187, 73-78[Medline] [Order article via Infotrieve]
  37. Jaswal, J. S., and Tracey, A. S. (1991) Inorg. Chem. 30, 3718-3722
  38. Campbell, N. J., Dengel, A. C., and Griffith, W. P. (1989) Polyhedron 8, 1379-1386[CrossRef]
  39. Butler, A., Clague, M. J., and Meister, G. E. (1994) Chem. Rev. 94, 625-638
  40. Posner, B. I., Faure, R., Burgess, J. W., Bevan, A. P., Lachance, D., Zhang-Sun, G., Fantus, I. G., Ng, J. B., Hall, D. A., Lum, B. S., and Shaver, A. (1994) J. Biol. Chem. 269, 4596-4604[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.